Article
The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients.
Seminars in thrombosis and hemostasis - 1 Dec 2003
Knoefler Ralf, Ludwig Kathrin, Kostka Heike, Kuhlisch Eberhard, Siegert Gabriele, Suttorp Meinolf
Abstract excerpt
The thrombin activatable fibrinolysis inhibitor (TAFI) influences the pathways regulating fibrin formation and deposition. The enormous TAFI plasma level variability present in adults may be explained by a combination of two polymorphisms in the TAFI gene (+1542C>G; 505G>A). We aimed to correlate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.